查看完整行情页>>

|

货币单位:美元(USD)

阿玛琳

Amarin Corp. Plc (amrn)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Jonathan Provoost Jonathan Provoost is currently working as the Secretary, Chief Legal & Compliance Officer & EVP at Amarin Corp. Plc. He has a degree in undergraduate studies from the State University of New York College at Oswego, a graduate degree from Lehigh University, and another graduate degree from Pace Law School.
Odysseas Demosthenes Kostas Odysseas Demosthenes Kostas is currently the Chairman at Amarin Corp. Plc, Director at Innoviva, Inc., Independent Director at Armata Pharmaceuticals, Inc., and Senior Managing Director at Sarissa Capital Acquisition Corp. Previously, he served as an Independent Director at Enzon Pharmaceuticals, Inc. from 2013 to 2020, Director at Mast Therapeutics, Inc. from 2010 to 2011, Director at International Strategy & Investment Group LLC from 2011 to 2015, and Director at International Strategy & Investment, Inc. from 2011 to 2015. He is also a Member of Yale New Haven Health Services Corp. Dr. Kostas obtained his undergraduate degree from Massachusetts Institute of Technology and his doctorate degree from The University of Texas Southwestern Medical Center.
Derek Kalinowski Derek Kalinowski is currently the SVP-Manufacturing Operations at Amarin Corp. Plc since 2011. Prior to this, he worked as the Head-Supply Chain Division at Enzon Pharmaceuticals, Inc. and as the Vice President-Supply Chain at Leadiant Biosciences, Inc.
Nabil A. Abadir Nabil A. Abadir is currently the Global Chief Medical Officer & Senior VP at Amarin Corp. Plc. Prior to this role, he served as the Executive VP-Medical & Scientific Affairs at Clementia Pharmaceuticals, Inc.
Thomas Reilly Thomas Reilly is currently the CFO, Executive VP, Head-Global HR & Finance at Amarin Corp. Plc. Previously, he worked as the Head-Finance Medicines Business at Allergan, Inc. and as the Chief Financial & Accounting Officer at CARA Therapeutics, Inc. He completed his undergraduate degree at Manhattan College and holds an MBA from Seton Hall University.
David Keenan David Keenan is currently the Director at Secure Remote Payments Council and the EVP-Technical Operations & President-Europe at Amarin Corp. Plc. Previously, he held positions such as Managing Director at United Air Lines, Inc., Director at Mallinckrodt Plc, General Manager-ACCEL at Fiserv, Inc., Systems Programmer at Fifth Third Bank, NA (Cincinnati, Ohio), Senior Vice President at Mastercard, Inc., Systems Programmer at Fifth Third Bank Processing Solutions, Inc., Senior Vice President-Business Development at eCash Technologies, Inc., and Senior Vice President at Mastercard International, Inc. He obtained his undergraduate degree from the University of Miami.
Steven B. Ketchum Steven B. Ketchum is currently the Chief Scientific Officer, President-R&D, and EVP at Amarin Corp. Plc. He previously worked as the Senior Director of Regulatory Affairs at ALZA Corp. from 1994 to 2002. From 2002 to 2007, he served as the Senior VP of Operations & Regulatory Affairs at IntraBiotics Pharmaceuticals, Inc. Additionally, he held the position of Senior VP of Medical Affairs, Research & Development at Reliant Pharmaceuticals LLC from 2005 to 2008. Dr. Ketchum was an Independent Director at Sunesis Pharmaceuticals, Inc. from 2008 to 2021. He obtained his undergraduate degree from Stanford University and his doctorate from University College London.
Aaron D. Berg Aaron D. Berg is currently the Director at the American Heart Association, Inc. He is also the President-US & Executive Vice President at Amarin Corp. Plc since 2023. Previously, he served as the President, Chief Executive Officer & Director at Essentialis, Inc. from 2009 to 2012. Mr. Berg also held positions at Bristol Myers Squibb Co., Oscient Pharmaceuticals Corp., Schering-Plough Corp., KOS Pharmaceuticals, Inc., and GlaxoSmithKline, Inc. He obtained his undergraduate degree from the University of Maryland.
Patrick Holt Mr. Patrick Holt is a President, Chief Executive Officer & Director at Amarin Corp. Plc and an Independent Non-Executive Director at Hugel, Inc. He is on the Board of Directors at Amarin Corp. Plc, Hugel, Inc. and Ascenda Loyalty Pte Ltd. Mr. Holt was previously employed as a Vice President by Allergan, Inc., a President by Cardinal Health, Inc., and a President Director by Merck & Co., Inc. He received his undergraduate degree from Monash University and a graduate degree from Harvard Business School.
Diane E. Sullivan Diane E. Sullivan currently works at Amarin Corp. Plc, as Independent Director from 2023 and Lexicon Pharmaceuticals, Inc., as Director from 2023. Ms. Sullivan also formerly worked at OrthogenRx, Inc., as Director from 2018 to 2022, National Association of Specialty Pharmacy, as Director, Pfizer Inc., as VP-Specialty Care Payer & Channel Group from 2009 to 2013, The Medicines Co., as Chief Commercial Officer from 2018 to 2020, and Dalcor Pharmaceuticals US LLC, as Chief Commercial Officer from 2020 to 2021. Ms. Sullivan received her undergraduate degree from Dickinson College.
Oliver O’Connor Oliver O’Connor currently works at Irish Pharmaceutical Healthcare Association Ltd., as Chief Executive Officer, Amarin Corp. Plc, as Independent Director from 2023, and The Irish Medicines Verification Organisation, as Director.
Paul Cohen Paul Cohen is an Independent Director at Amarin Corp. Plc since 2023 and an Associate Professor at The Rockefeller University since 2015. He holds a doctorate degree from The Rockefeller University and Weill Cornell Medical College, and an undergraduate degree from Harvard College.
Mark A. Dipaolo Mark A. Dipaolo is currently the Chairman at Innoviva, Inc., an Independent Director at Amarin Corp. Plc, and a Senior Managing Director at Sarissa Capital Acquisition Corp. Previously, he served as an Independent Director at Novelion Therapeutics, Inc. and worked as an Attorney at Willkie Farr & Gallagher LLP. Mr. Dipaolo obtained his undergraduate degree from Fordham University and his graduate degree from Georgetown University Law Center.
Louis E. Sterling Louis E. Sterling is an Independent Director at Amarin Corp. Plc since 2023. Prior to this, he worked as a Director at BZAM Ltd. from 2021 to 2023, a Managing Director at The BondFactor Co. LLC, and a Director at Levine Leichtman Capital Partners, Inc. He also worked as an Associate at Lincolnshire Management, Inc. from 2006 to 2008. Mr. Sterling received his undergraduate degree from Howard University, an MBA from Harvard Business School, and a graduate degree from Harvard Law School.
Patrice Bonfiglio Patrice Bonfiglio is an Independent Director at Amarin Corp. Plc and the Chief Financial Officer at Sarissa Capital Acquisition Corp. She previously worked as an Associate & Fund Accountant at Pequot Capital Management, Inc., a Senior Accountant at Ridgefield Capital Asset Management LP, an Operations Manager at Arrowhawk Capital Partners LLC, and the Head-Operations at Arbalet Capital Management LP. Bonfiglio received an undergraduate degree from Temple University (Pennsylvania).
Keith L. Horn Keith L. Horn is the founder and the Managing Member of Loring Capital Advisors LLC, which was founded in 2016. He is currently the Director of Empire Resorts, Inc., Amarin Corp. Plc, The Laundry Chute LLC, PeacePlayers International, Binghamton University Foundation Housing Corp., 5071, Inc., ShopOne Centers REIT, Inc., Sarissa Capital Acquisition Corp., Caliper Holdings, and a member of the Advisory board at Sharp Alpha Advisors LLC. Mr. Horn previously served as the Chief Executive Officer, Secretary & Director of Forest Road Acquisition Corp. from 2020 to 2021, Independent Director of Empire Resorts, Inc. from 2016 to 2019, Director of Managed Funds Association from 2011 to 2015, Independent Director of Forest Road Acquisition Corp. II from 2021 to 2023, and Chief Operating Officer of Elliott Management Corp. from 2003 to 2015. He also held positions at Merrill Lynch, Pierce, Fenner & Smith, Inc. Mr. Horn received his undergraduate degree from State University of New York at Binghamton and his graduate degree from Georgetown University Law Center.